An increase in the price the NHS pays for medicines will be “necessary” to prevent pharmaceutical investments from continuing to leave the UK, science minister Lord Patrick Vallance has said.
Major firms have shelved or paused planned UK pharmaceutical industry investments this year, and industry bosses recently told MPs a “difficult” environment and pressure on pricing had made Britain a less attractive investment environment than other countries such as the US.
